← Patents

Patents · 2022 · pending

Treatment of GPAM Related Diseases and Disorders

siRNA and antisense oligonucleotides targeting GPAM, for metabolic disorders including liver and cardiovascular conditions.

Filings
2
Status
Pending
First priority
Jun 21, 2022